Journal Impact Factor 4.7 (2023) 5-year Journal Impact Factor 5.0 (2023) Submission to first decision (median) 4 days Downloads 572,849 (2023) Latest articles Talimogene laherparepvec (T-VEC) and Emerging Intralesional Immunotherapies for Metastatic Melanoma: A Review ...
Online ISSN:1791-2431 Sign up for eToc alerts Recommend to Library Full Size Image Journal Metrics Impact Factor:3.8 CiteScore:8.5 CiteScore Rank:Q1: #74/404Oncology Source Normalized Impact per Paper (SNIP):0.719 SCImago Journal Rank (SJR):0.864...
1.2Impact Factor All issues Formerly known asGynecologic Oncology Case Reports; 2024 — Volumes 51-56 Volume 56 In progress(December 2024) Volume 55 October 2024 Volume 54 August 2024 Volume 53 June 2024 Volume 52 April 2024 Volume 51
YearImpact Factor (IF)Total ArticlesTotal Cites 2023 (2024 update)2.3-- 20222.8-3917 20212.874-3900 20203.2013013694 20192.8261812684 20182.4331112268 20171.9351082068 20161.7361091884 20151.9401531735 20141.8551241528 20131.8061091397 20121.5551401232 20111.366133916 ...
2023年6月28日,科睿唯安(Clarivate Analytics,原汤森路透知识产权与科技事业部)发布了一年一度的期刊引证报告(Journal Citation Reports)。AME旗下杂志 Chinese Clinical Oncology (中文名为《中国临床肿瘤学》杂志,简称 CCO 杂志,图2)获得首个影响因子(Impact Factor,简称IF):2.8分。
Year Impact Factor (IF) Total Articles Total Cites 2023 (2024 update) 2.4 - - 2022 3.3 - 5463 2021 3.850 - 5193 2020 3.402 302 4585 2019 2.879 185 3249 2018 2.503 146 2902 2017 2.610 134 2667 2016 2.064 154 2204 2015 1.806 161 1945 2014 2.128 152 1716 2013 2.170 152 1474 2012 ...
当前的肿瘤学报告(Current Oncology Reports)是一本由Springer US出版的一本ONCOLOGY学术刊物,主要报道ONCOLOGY相关领域研究成果与实践。本刊已入选来源期刊,该刊创刊于1999年,出版周期12 issues per year。2021-2022年最新版WOS分区等级:Q1,2023年发布的影响因子为4.7,CiteScore指数8.5,SJR指数1.498。本刊非开放获取期刊...
studies on the mechanism of action of carcinogens and therapeutic agents, reports dealing with cancer prevention and epidemiology, and clinical trials delineating effective new therapeutic regimens.
press release. These forward-looking statements are subject to risks and uncertainties, including, without limitation, those discussed in the section titled “Risk Factors” in Olema’s Annual Report on Form 10-K for the year ended December 31, 2023, and future filings and reports that Olema ...
The 2024 edition of Journal Citation Reports® cites the 2023 journal impact factor (JIF) forWJCOas 2.6; JIF without journal self cites: 2.6; 5-year JIF: 2.7; JIF Rank: 175/322 in oncology; JIF Quartile: Q3; and 5-year JIF Quartile: Q3. ...